111 (YI) Preferred Stock Liabilities (2017)
111 (YI) reported Preferred Stock Liabilities of $227.8 million for Q4 2017.
111 (YI) Preferred Stock Liabilities (2017) Analysis & Trends
111 (YI) has 1 years of Preferred Stock Liabilities data on file, last reported at $227.8 million in Q4 2017.
- For the quarter ending Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $227.8 million; the trailing twelve-month figure through Dec 2017 stood at $227.8 million (changed N/A YoY), and the FY2017 full-year result was $223.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $227.8 million in Q4 2017.
- In the past five years, Preferred Stock Liabilities ranged from a high of $227.8 million in Q4 2017 to a low of $227.8 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | - |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | - |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | - |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | - |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | - |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 227.76 Mn |